Protara Therapeutics (TARA) Return on Capital Employed Growth (1y) (2015 - 2026)
Protara Therapeutics (TARA) Return on Capital Employed Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,538.84 Bn | 65,538.56 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 469.46 Bn | 464.67 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.69 Bn | 115.45 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.41 Bn | 61.65 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.84 Bn | 62.84 Bn | - | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | 2,400.00 |
| 10 | Protara Therapeutics | 232.17 Mn | 232.17 Mn | - | -592.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -592.00 |
| Dec 31, 2025 | -10.00 |
| Sep 30, 2025 | 899.00 |
| Jun 30, 2025 | 1,836.00 |
| Mar 31, 2025 | 3,660.00 |
| Dec 31, 2024 | 1,747.00 |
| Sep 30, 2024 | 3,335.00 |
| Jun 30, 2024 | 1,652.00 |
| Mar 31, 2024 | -348.00 |
| Dec 31, 2023 | -267.00 |
| Sep 30, 2023 | -5,921.00 |
| Jun 30, 2023 | -4,604.00 |
| Mar 31, 2023 | -3,643.00 |
| Dec 31, 2022 | -2,601.00 |
| Sep 30, 2022 | -8.00 |
| Jun 30, 2022 | -312.00 |
| Mar 31, 2022 | -783.00 |
| Dec 31, 2021 | -1,017.00 |
| Sep 30, 2021 | -347.00 |
| Jun 30, 2021 | 1,206.00 |